Sunday, December 30, 2018

BREAKING: FDA Approves New Parkinsons Drug Funded by MJFF

I see nothing from our fucking failures of stroke associations that suggests they are even working on anything that might solve all the problems in stroke. Do they not even have enough brains to contact MJFF and use their processes to solve stroke? 5 easy steps. 

1.  Describe the problem exactly. 
2.  Write an RFP to researchers to solve that problem.
3.  Fund them with foundation grants.
4.  Write stroke rehab protocols based on the research.
5.  Get the Nobel prize in medicine  

 

BREAKING: FDA Approves New PD Drug Funded by MJFF

On Friday, December 21, 2018, the U.S. Food and Drug Administration approved Inbrija, an inhaled levodopa powder, for the treatment of "off" episodes when Parkinson's symptoms are not well controlled with oral medication.

This highly anticipated news marks another significant milestone in The Michael J. Fox Foundation's (MJFF) short history. This is the first regulatory approval of a Parkinson's treatment directly funded by the Foundation.

MJFF's "de-risking" approach identifies, funds and keeps the most promising, high-risk, high-reward ideas in Parkinson's research moving forward. Read more about how we funded Inbrija in early stages of development, helping its maker drive the new treatment across the finish line and into patients' hands.


Read More 

 
P.S. It's not too late to help MJFF speed the next breakthrough therapy from the laboratory to pharmacy shelves and Parkinson's patients. Your year-end gift today will be put to work right away to help fulfill the promise of tomorrow's new research and treatments.

No comments:

Post a Comment